The invention relates to application of
pyruvate kinase (PKM), triosephosphate
isomerase (TPI1), alpha-
enolase (ENO1) and
lactic dehydrogenase (LDHB) in
urine in preparation of medicines for exercise function evaluation (
exercise intensity, exercise density,
exercise duration, exercise function, exercise posture and physiological state), exercise risk prediction, exerciser physique evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise function evaluation, exercise and scientific exercise guidance, exercise scheme screening and other reagents are applied. Research proves that the proteins PKM, TPI1, ENO1 and LDHB in
urine are key proteins for exercise
training monitoring for the first time. Compared with the prior art, the expression of the four proteins in a
urine sample after movement is obviously increased. The sensitivity and the specificity of various purposes such as function evaluation, exercise risk prediction and scientific exercise guidance of exercise training can be improved through independent use of one of the components and
combined use of multiple components.